-
MAMA-MIA: A Large-Scale Multi-Center Breast Cancer DCE-MRI Benchmark Dataset with Expert Segmentations
Authors:
Lidia Garrucho,
Claire-Anne Reidel,
Kaisar Kushibar,
Smriti Joshi,
Richard Osuala,
Apostolia Tsirikoglou,
Maciej Bobowicz,
Javier del Riego,
Alessandro Catanese,
Katarzyna Gwoździewicz,
Maria-Laura Cosaka,
Pasant M. Abo-Elhoda,
Sara W. Tantawy,
Shorouq S. Sakrana,
Norhan O. Shawky-Abdelfatah,
Amr Muhammad Abdo-Salem,
Androniki Kozana,
Eugen Divjak,
Gordana Ivanac,
Katerina Nikiforaki,
Michail E. Klontzas,
Rosa García-Dosdá,
Meltem Gulsun-Akpinar,
Oğuz Lafcı,
Ritse Mann
, et al. (8 additional authors not shown)
Abstract:
Current research in breast cancer Magnetic Resonance Imaging (MRI), especially with Artificial Intelligence (AI), faces challenges due to the lack of expert segmentations. To address this, we introduce the MAMA-MIA dataset, comprising 1506 multi-center dynamic contrast-enhanced MRI cases with expert segmentations of primary tumors and non-mass enhancement areas. These cases were sourced from four…
▽ More
Current research in breast cancer Magnetic Resonance Imaging (MRI), especially with Artificial Intelligence (AI), faces challenges due to the lack of expert segmentations. To address this, we introduce the MAMA-MIA dataset, comprising 1506 multi-center dynamic contrast-enhanced MRI cases with expert segmentations of primary tumors and non-mass enhancement areas. These cases were sourced from four publicly available collections in The Cancer Imaging Archive (TCIA). Initially, we trained a deep learning model to automatically segment the cases, generating preliminary segmentations that significantly reduced expert segmentation time. Sixteen experts, averaging 9 years of experience in breast cancer, then corrected these segmentations, resulting in the final expert segmentations. Additionally, two radiologists conducted a visual inspection of the automatic segmentations to support future quality control studies. Alongside the expert segmentations, we provide 49 harmonized demographic and clinical variables and the pretrained weights of the well-known nnUNet architecture trained using the DCE-MRI full-images and expert segmentations. This dataset aims to accelerate the development and benchmarking of deep learning models and foster innovation in breast cancer diagnostics and treatment planning.
△ Less
Submitted 19 June, 2024;
originally announced June 2024.
-
Enabling Global Image Data Sharing in the Life Sciences
Authors:
Peter Bajcsy,
Sreenivas Bhattiprolu,
Katy Boerner,
Beth A Cimini,
Lucy Collinson,
Jan Ellenberg,
Reto Fiolka,
Maryellen Giger,
Wojtek Goscinski,
Matthew Hartley,
Nathan Hotaling,
Rick Horwitz,
Florian Jug,
Anna Kreshuk,
Emma Lundberg,
Aastha Mathur,
Kedar Narayan,
Shuichi Onami,
Anne L. Plant,
Fred Prior,
Jason Swedlow,
Adam Taylor,
Antje Keppler
Abstract:
Coordinated collaboration is essential to realize the added value of and infrastructure requirements for global image data sharing in the life sciences. In this White Paper, we take a first step at presenting some of the most common use cases as well as critical/emerging use cases of (including the use of artificial intelligence for) biological and medical image data, which would benefit tremendou…
▽ More
Coordinated collaboration is essential to realize the added value of and infrastructure requirements for global image data sharing in the life sciences. In this White Paper, we take a first step at presenting some of the most common use cases as well as critical/emerging use cases of (including the use of artificial intelligence for) biological and medical image data, which would benefit tremendously from better frameworks for sharing (including technical, resourcing, legal, and ethical aspects). In the second half of this paper, we paint an ideal world scenario for how global image data sharing could work and benefit all life sciences and beyond. As this is still a long way off, we conclude by suggesting several concrete measures directed toward our institutions, existing imaging communities and data initiatives, and national funders, as well as publishers. Our vision is that within the next ten years, most researchers in the world will be able to make their datasets openly available and use quality image data of interest to them for their research and benefit. This paper is published in parallel with a companion White Paper entitled Harmonizing the Generation and Pre-publication Stewardship of FAIR Image Data, which addresses challenges and opportunities related to producing well-documented and high-quality image data that is ready to be shared. The driving goal is to address remaining challenges and democratize access to everyday practices and tools for a spectrum of biomedical researchers, regardless of their expertise, access to resources, and geographical location.
△ Less
Submitted 2 February, 2024; v1 submitted 23 January, 2024;
originally announced January 2024.
-
FUTURE-AI: International consensus guideline for trustworthy and deployable artificial intelligence in healthcare
Authors:
Karim Lekadir,
Aasa Feragen,
Abdul Joseph Fofanah,
Alejandro F Frangi,
Alena Buyx,
Anais Emelie,
Andrea Lara,
Antonio R Porras,
An-Wen Chan,
Arcadi Navarro,
Ben Glocker,
Benard O Botwe,
Bishesh Khanal,
Brigit Beger,
Carol C Wu,
Celia Cintas,
Curtis P Langlotz,
Daniel Rueckert,
Deogratias Mzurikwao,
Dimitrios I Fotiadis,
Doszhan Zhussupov,
Enzo Ferrante,
Erik Meijering,
Eva Weicken,
Fabio A González
, et al. (95 additional authors not shown)
Abstract:
Despite major advances in artificial intelligence (AI) for medicine and healthcare, the deployment and adoption of AI technologies remain limited in real-world clinical practice. In recent years, concerns have been raised about the technical, clinical, ethical and legal risks associated with medical AI. To increase real world adoption, it is essential that medical AI tools are trusted and accepted…
▽ More
Despite major advances in artificial intelligence (AI) for medicine and healthcare, the deployment and adoption of AI technologies remain limited in real-world clinical practice. In recent years, concerns have been raised about the technical, clinical, ethical and legal risks associated with medical AI. To increase real world adoption, it is essential that medical AI tools are trusted and accepted by patients, clinicians, health organisations and authorities. This work describes the FUTURE-AI guideline as the first international consensus framework for guiding the development and deployment of trustworthy AI tools in healthcare. The FUTURE-AI consortium was founded in 2021 and currently comprises 118 inter-disciplinary experts from 51 countries representing all continents, including AI scientists, clinicians, ethicists, and social scientists. Over a two-year period, the consortium defined guiding principles and best practices for trustworthy AI through an iterative process comprising an in-depth literature review, a modified Delphi survey, and online consensus meetings. The FUTURE-AI framework was established based on 6 guiding principles for trustworthy AI in healthcare, i.e. Fairness, Universality, Traceability, Usability, Robustness and Explainability. Through consensus, a set of 28 best practices were defined, addressing technical, clinical, legal and socio-ethical dimensions. The recommendations cover the entire lifecycle of medical AI, from design, development and validation to regulation, deployment, and monitoring. FUTURE-AI is a risk-informed, assumption-free guideline which provides a structured approach for constructing medical AI tools that will be trusted, deployed and adopted in real-world practice. Researchers are encouraged to take the recommendations into account in proof-of-concept stages to facilitate future translation towards clinical practice of medical AI.
△ Less
Submitted 8 July, 2024; v1 submitted 11 August, 2023;
originally announced September 2023.
-
Report of the Medical Image De-Identification (MIDI) Task Group -- Best Practices and Recommendations
Authors:
David A. Clunie,
Adam Flanders,
Adam Taylor,
Brad Erickson,
Brian Bialecki,
David Brundage,
David Gutman,
Fred Prior,
J Anthony Seibert,
John Perry,
Judy Wawira Gichoya,
Justin Kirby,
Katherine Andriole,
Luke Geneslaw,
Steve Moore,
TJ Fitzgerald,
Wyatt Tellis,
Ying Xiao,
Keyvan Farahani
Abstract:
This report addresses the technical aspects of de-identification of medical images of human subjects and biospecimens, such that re-identification risk of ethical, moral, and legal concern is sufficiently reduced to allow unrestricted public sharing for any purpose, regardless of the jurisdiction of the source and distribution sites. All medical images, regardless of the mode of acquisition, are c…
▽ More
This report addresses the technical aspects of de-identification of medical images of human subjects and biospecimens, such that re-identification risk of ethical, moral, and legal concern is sufficiently reduced to allow unrestricted public sharing for any purpose, regardless of the jurisdiction of the source and distribution sites. All medical images, regardless of the mode of acquisition, are considered, though the primary emphasis is on those with accompanying data elements, especially those encoded in formats in which the data elements are embedded, particularly Digital Imaging and Communications in Medicine (DICOM). These images include image-like objects such as Segmentations, Parametric Maps, and Radiotherapy (RT) Dose objects. The scope also includes related non-image objects, such as RT Structure Sets, Plans and Dose Volume Histograms, Structured Reports, and Presentation States. Only de-identification of publicly released data is considered, and alternative approaches to privacy preservation, such as federated learning for artificial intelligence (AI) model development, are out of scope, as are issues of privacy leakage from AI model sharing. Only technical issues of public sharing are addressed.
△ Less
Submitted 1 April, 2023; v1 submitted 18 March, 2023;
originally announced March 2023.
-
medigan: a Python library of pretrained generative models for medical image synthesis
Authors:
Richard Osuala,
Grzegorz Skorupko,
Noussair Lazrak,
Lidia Garrucho,
Eloy García,
Smriti Joshi,
Socayna Jouide,
Michael Rutherford,
Fred Prior,
Kaisar Kushibar,
Oliver Diaz,
Karim Lekadir
Abstract:
Synthetic data generated by generative models can enhance the performance and capabilities of data-hungry deep learning models in medical imaging. However, there is (1) limited availability of (synthetic) datasets and (2) generative models are complex to train, which hinders their adoption in research and clinical applications. To reduce this entry barrier, we propose medigan, a one-stop shop for…
▽ More
Synthetic data generated by generative models can enhance the performance and capabilities of data-hungry deep learning models in medical imaging. However, there is (1) limited availability of (synthetic) datasets and (2) generative models are complex to train, which hinders their adoption in research and clinical applications. To reduce this entry barrier, we propose medigan, a one-stop shop for pretrained generative models implemented as an open-source framework-agnostic Python library. medigan allows researchers and developers to create, increase, and domain-adapt their training data in just a few lines of code. Guided by design decisions based on gathered end-user requirements, we implement medigan based on modular components for generative model (i) execution, (ii) visualisation, (iii) search & ranking, and (iv) contribution. The library's scalability and design is demonstrated by its growing number of integrated and readily-usable pretrained generative models consisting of 21 models utilising 9 different Generative Adversarial Network architectures trained on 11 datasets from 4 domains, namely, mammography, endoscopy, x-ray, and MRI. Furthermore, 3 applications of medigan are analysed in this work, which include (a) enabling community-wide sharing of restricted data, (b) investigating generative model evaluation metrics, and (c) improving clinical downstream tasks. In (b), extending on common medical image synthesis assessment and reporting standards, we show Fréchet Inception Distance variability based on image normalisation and radiology-specific feature extraction.
△ Less
Submitted 23 February, 2023; v1 submitted 28 September, 2022;
originally announced September 2022.
-
Lung cancer screening with low-dose CT scans using a deep learning approach
Authors:
Jason L. Causey,
Yuanfang Guan,
Wei Dong,
Karl Walker,
Jake A. Qualls,
Fred Prior,
Xiuzhen Huang
Abstract:
Lung cancer is the leading cause of cancer deaths. Early detection through low-dose computed tomography (CT) screening has been shown to significantly reduce mortality but suffers from a high false positive rate that leads to unnecessary diagnostic procedures. Quantitative image analysis coupled to deep learning techniques has the potential to reduce this false positive rate. We conducted a comput…
▽ More
Lung cancer is the leading cause of cancer deaths. Early detection through low-dose computed tomography (CT) screening has been shown to significantly reduce mortality but suffers from a high false positive rate that leads to unnecessary diagnostic procedures. Quantitative image analysis coupled to deep learning techniques has the potential to reduce this false positive rate. We conducted a computational analysis of 1449 low-dose CT studies drawn from the National Lung Screening Trial (NLST) cohort. We applied to this cohort our newly developed algorithm, DeepScreener, which is based on a novel deep learning approach. The algorithm, after the training process using about 3000 CT studies, does not require lung nodule annotations to conduct cancer prediction. The algorithm uses consecutive slices and multi-task features to determine whether a nodule is likely to be cancer, and a spatial pyramid to detect nodules at different scales. We find that the algorithm can predict a patient's cancer status from a volumetric lung CT image with high accuracy (78.2%, with area under the Receiver Operating Characteristic curve (AUC) of 0.858). Our preliminary framework ranked 16th of 1972 teams (top 1%) in the Data Science Bowl 2017 (DSB2017) competition, based on the challenge datasets. We report here the application of DeepScreener on an independent NLST test set. This study indicates that the deep learning approach has the potential to significantly reduce the false positive rate in lung cancer screening with low-dose CT scans.
△ Less
Submitted 1 June, 2019;
originally announced June 2019.
-
Highly accurate model for prediction of lung nodule malignancy with CT scans
Authors:
Jason Causey,
Junyu Zhang,
Shiqian Ma,
Bo Jiang,
Jake Qualls,
David G. Politte,
Fred Prior,
Shuzhong Zhang,
Xiuzhen Huang
Abstract:
Computed tomography (CT) examinations are commonly used to predict lung nodule malignancy in patients, which are shown to improve noninvasive early diagnosis of lung cancer. It remains challenging for computational approaches to achieve performance comparable to experienced radiologists. Here we present NoduleX, a systematic approach to predict lung nodule malignancy from CT data, based on deep le…
▽ More
Computed tomography (CT) examinations are commonly used to predict lung nodule malignancy in patients, which are shown to improve noninvasive early diagnosis of lung cancer. It remains challenging for computational approaches to achieve performance comparable to experienced radiologists. Here we present NoduleX, a systematic approach to predict lung nodule malignancy from CT data, based on deep learning convolutional neural networks (CNN). For training and validation, we analyze >1000 lung nodules in images from the LIDC/IDRI cohort. All nodules were identified and classified by four experienced thoracic radiologists who participated in the LIDC project. NoduleX achieves high accuracy for nodule malignancy classification, with an AUC of ~0.99. This is commensurate with the analysis of the dataset by experienced radiologists. Our approach, NoduleX, provides an effective framework for highly accurate nodule malignancy prediction with the model trained on a large patient population. Our results are replicable with software available at http://bioinformatics.astate.edu/NoduleX.
△ Less
Submitted 5 February, 2018;
originally announced February 2018.